Marco Ruella

Human chimeric antigen receptor macrophages for cancer immunotherapy

Michael Klichinsky, Marco Ruella, Olga Shestova et al. · Nature Biotechnology · 2020 · 1.3K citations · Full text

Cancer Immunosurveillance, Immunology, Tumor Immunity +4

Convergence of Acquired Mutations and Alternative Splicing of <i>CD19</i> Enables Resistance to CART-19 Immunotherapy

Elena Sotillo, David M. Barrett, Kathryn L. Black et al. · Cancer Discovery · 2015 · 1.2K citations · Full text

Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell

Marco Ruella, Jun Xu, David M. Barrett et al. · Nature Medicine · 2018 · 620 citations · Full text

Autoimmune Disease, Immunology, Antigen Processing +5

Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies

Marco Ruella, David M. Barrett, Saad S. Kenderian et al. · Journal of Clinical Investigation · 2016 · 549 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Immunoediting +22

Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor–modified T cells

Saar Gill, Sarah K. Tasian, Marco Ruella et al. · Blood · 2014 · 481 citations · Full text